CSF2 and autoimmune pulmonary alveolar proteinosis: Subsequently, we identified a 66-year-old female with unremitting, slowly progressive autoimmune PAP (serum GM-CSF autoantibody: 109.1 mcg/ml) who had not received WLL or other therapy of PAP.